Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CHPA Pushes Federal Legislation, PSAs To Curb Dextromethorphan Abuse

This article was originally published in The Tan Sheet

Executive Summary

The Consumer Healthcare Products Association is actively working to encourage introduction of companion legislation in the Senate for a bill that would restrict the sale and distribution of bulk forms of dextromethorphan
Advertisement

Related Content

Bill To Restrict Bulk DXM Sales Reintroduced In House
Bill To Restrict Bulk DXM Sales Reintroduced In House
Bill To Restrict Bulk DXM Sales Reintroduced In House
Dextromethorphan Bulk-Sale Limit Clears House, But Stalls In Senate
Dextromethorphan Bulk-Sale Limit Clears House, But Stalls In Senate
Dextromethorphan Bulk-Sale Limit Clears House, But Stalls In Senate
DXM legislation
Dextromethorphan bill
FDA Dextromethorphan Advisory Marks Growing Concern Over Abuse
CHPA Launches Meth Watch Program With $1 Mil. In “Seed Money”

Topics

Advertisement
UsernamePublicRestriction

Register

PS099386

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel